Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5197102
Max Phase: Preclinical
Molecular Formula: C20H18ClN3O2
Molecular Weight: 367.84
Associated Items:
ID: ALA5197102
Max Phase: Preclinical
Molecular Formula: C20H18ClN3O2
Molecular Weight: 367.84
Associated Items:
Canonical SMILES: O=C(Nc1ccc(Cl)cc1)[C@]12ON=C(c3cccnc3)[C@H]1[C@@H]1CC[C@H]2C1
Standard InChI: InChI=1S/C20H18ClN3O2/c21-15-5-7-16(8-6-15)23-19(25)20-14-4-3-12(10-14)17(20)18(24-26-20)13-2-1-9-22-11-13/h1-2,5-9,11-12,14,17H,3-4,10H2,(H,23,25)/t12-,14+,17-,20-/m1/s1
Standard InChI Key: UTDQICSADFPUBS-CIEYIMOZSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 367.84 | Molecular Weight (Monoisotopic): 367.1088 | AlogP: 3.89 | #Rotatable Bonds: 3 |
Polar Surface Area: 63.58 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.59 | CX Basic pKa: 4.21 | CX LogP: 3.59 | CX LogD: 3.59 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.89 | Np Likeness Score: -0.36 |
1. Yin L, Pan Y, Xue Y, Chen X, You T, Huang J, Xu Q, Hu Q.. (2022) Design, Synthesis, and Biological Evaluations of Pyridyl 4,5,6,7-Tetrahydro-4,7-Methanobenzo[d]isoxazoles as Potent and Selective Inhibitors of 11β-Hydroxylase., 65 (17.0): [PMID:35975976] [10.1021/acs.jmedchem.2c01037] |
Source(1):